Patents by Inventor Pleasant Fite Hooper

Pleasant Fite Hooper has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11497834
    Abstract: Disclosed herein is biocompatible composite material impregnated with antiinfective agents to reduce the rate of infection in patients with medical implants. Also disclosed herein is the utilization of super critical fluid (SCF) methodology to impregnate medical implant materials with antiinfective agents (e.g., antimicrobial, antibiofilm agents, etc.).
    Type: Grant
    Filed: November 2, 2021
    Date of Patent: November 15, 2022
    Assignee: BIO PROTECTANT TECHNOLOGIES, INC.
    Inventors: Joseph Frederick Buell, Pleasant Fite Hooper, Brandon Joseph Iglesias, Chad Joseph Roy
  • Publication number: 20120164671
    Abstract: Systems and methods are provided for monitoring a immunosuppressant drug level and renal function, hepatic function, or a combination thereof in a patient, comprising obtaining a small volume blood sample from the patient; determining the level of at least one immunosuppressant drug in the small volume blood sample and determining the level of a second immunosuppressant drug or analyzing the renal function, the hepatic function, or a combination thereof in the patient. In some embodiments, the immunosuppressant drug levels are determined using a liquid chromatography tandem mass spectrometry (LC-MS/MS) procedure. Also provided are kits for use in any of the systems and methods described herein.
    Type: Application
    Filed: February 29, 2012
    Publication date: June 28, 2012
    Inventor: Pleasant Fite Hooper
  • Publication number: 20090298106
    Abstract: Systems and methods are provided for monitoring a immunosuppressant drug level and renal function, hepatic function, or a combination thereof in a patient, comprising obtaining a small volume blood sample from the patient; determining the level of at least one immunosuppressant drug in the small volume blood sample and determining the level of a second immunosuppressant drug or analyzing the renal function, the hepatic function, or a combination thereof in the patient. In some embodiments, the immunosuppressant drug levels are determined using a liquid chromatography tandem mass spectrometry (LC-MS/MS) procedure. Also provided are kits for use in any of the systems and methods described herein.
    Type: Application
    Filed: June 1, 2009
    Publication date: December 3, 2009
    Applicant: Therapeutic Monitoring Services, L.L.C.
    Inventor: Pleasant Fite Hooper